Sector: MedicalNovo Nordisk A/S (NYSE: NVO)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 149 |
Technical : | 43 |
Performance : | 205 |
Overall: | 117 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 153 |
Technical : | 74 |
Performance : | 224 |
Overall: | 159 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 156 |
Technical : | 155 |
Performance : | 221 |
Overall: | 216 |
Number of Stocks: | 305 |
Headlines
- Dividend Capital Total Realty Trust Acquires Office Property in Princeton, NJ
Nov 03, 2009 06:28 PM | NVO
- Are you a Diabetes Champion?
Nov 03, 2009 01:06 PM | NVO, SNY
- Êtes-vous un Champion du Diabète?
Nov 03, 2009 01:06 PM | NVO, SNY
- Novo Nordisk A/S: Director/PDMR Shareholding
Nov 02, 2009 10:19 AM | NVO
- Transaction in Own Shares
Nov 02, 2009 10:09 AM | NVO
- Novo Nordisk A/S: Director/PDMR Shareholding
Oct 30, 2009 11:03 AM | NVO
- Novo Nordisk is Changing Possibilities in Hemophilia
Oct 30, 2009 09:01 AM | NVO
- Lab Group Recognizes the National Changing Diabetes Program for New Study on Quality Measures in Diabetes
Oct 29, 2009 04:32 PM | NVO
- 3rd Quarter Results
Oct 29, 2009 03:16 AM | NVO
- Trading Outlook for Generex Biotechnologies Corp. Issued by InvestorSoup.com
Oct 27, 2009 06:51 AM | GNBT, HSP, MNKD, NVO
- Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families
Aug 27, 2009 09:03 AM | NVO
- Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes
Aug 12, 2009 10:01 AM | NVO
- Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient Option
Aug 10, 2009 09:01 AM | NVO
- Novo Nordisk: Half-Yearly Report
Aug 06, 2009 03:52 AM | NVO, PFE, ZGEN
- Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America
Aug 05, 2009 08:31 AM | NVO
- Liraglutide Lowered Blood Sugar and Weight in African Americans With Type 2 Diabetes, Phase 3 Data Showed
Jul 27, 2009 11:00 AM | NVO
- Liraglutide Lowered Blood Sugar and Weight in African Americans With Type 2 Diabetes, Phase 3 Data Showed
Jul 25, 2009 09:10 AM | NVO
- NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care
Jul 23, 2009 09:03 AM | NVO
- FDA Approves NovoLog(R) Labeling Update
Jul 15, 2009 01:43 PM | NVO
- Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment
Jul 13, 2009 01:51 PM | NVO
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NVO
|
Compare to S&P
|
| YTD |
20.94 %
|
5.42 %
|
| 4 Weeks |
-0.30 %
|
-1.36 %
|
| 12 Weeks |
7.16 %
|
4.50 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -0.01 %
|
|
EPS Growth in Last Year: 69.81 %
|
|
Sales Growth in Last Quarter: 8.78 %
|
|
Sales Growth in Last Quarter: 59.78 %
|
|
